Marc Beer Is A CEO In The Biotechnology Sector Who Truly Cares About The People He Serves

Marc Beer has been serving in the biotechnology sector for over 25 years, and he has helped to grow many different companies during that time. He studied at Miami University and received his Bachelor of Science degree in business in 1987. He went to work in the pharmaceutical sales sector after finishing college and eventually worked with Genzyme as its vice president of global marketing. Beer was able to make a huge difference by addressing the needs of an underserved group of people through his marketing efforts and was forever changed by doing so.

During the earlier part of the 2000s, Marc Beer decided to start up his first company, which was named VIA CELL. This biotechnology company had 300 employees, and it went public during the mid-2000s. It focused on collecting and preserving umbilical cord blood stem cells, which could be used to treat various ailments that people suffered from. He eventually sold the company for $300 million to PerkinElmer right before his wife passed away from a pulmonary embolism. Learn more: https://www.bloomberg.com/research/stocks/people/person.asp?personId=1285777&privcapId=47636573

Marc Beer focused on raising his children after his wife passed away, and it was one of his kids who inspired him to get back to work a couple of years later. He had always taught his children to live their lives with purpose, and his daughter reminded him of his own words. He got back to work, and some years later, he helped to found Renovia. He continues to serve as the company’s chairman and CEO today. The company was started up when Beer partnered up with Yolanda Lorie and Dr. Iglesias in order to create therapeutic diagnostic devices for women who suffer from pelvic floor diseases.

In 2018, all of the hard work of Marc Beer paid off when Renovia came out with its first product, which is named Leva. The Food and Drug Administration approved Leva, and he was able to go on to get venture capital funding and a Series B round of funding. Beer commented on the Series B funding by saying that his company was thrilled to be supported by a group of the top healthcare investors. He went on to talk more about the details of his company and how it will help to lower the cost of healthcare for women in the future.

Marc Beer serves Renovia as its chief executive officer and chairman, and he has been successfully running the company for years. In the past, he has also served with Good Start Genetics, Inc. as its founding chairman of the board as well as its chairman of the compensation committee. He also served with the Miami University Business Advisory Council as a member and continues to do what he feels is right by helping to improve the biotechnology industry.

Follow Marc Beer on Facebook